Differential effects of Δ9-tetrahydrocannabinol dosing on correlates of schizophrenia in the sub-chronic PCP rat model

Pharmacology, Toxicology and Pharmaceutical Science

• Anandamide 25%
• Animal 75%
• Cannabis 50%
• Dexamphetamine 50%
• Dopamine 50%
• Molecular Marker 25%
• Negative Syndrome 25%
• Pathophysiology 25%
• Phencyclidine 25%
• Positive Syndrome 25%
• Psychosis 25%
• Rat 75%
• Rat Model 50%
• Schizophrenia 100%
• Self-Medication 25%
• Symptom 25%
• Tetrahydrocannabinol 50%

Neuroscience

• Amphetamine 50%
• Anandamide 25%
• Brain 50%
• Cannabis 50%
• Dementia Praecox 100%
• Dopamine 50%
• Negative Syndrome 25%
• Neuron 50%
• Nucleus Accumbens 25%
• Phencyclidine 25%
• Positive Syndrome 25%
• Psychosis 25%
• Social Interaction 25%
• Tetrahydrocannabinol 50%
• Ventral Tegmental Area 50%